US Pharma MarketingHims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business to selling branded GLP-1 weight loss treatments, shiftin Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business to selling branded GLP-1 weight loss treatments, shifting away from compounded weight loss drugs.
Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business to selling branded GLP-1 weight loss treatments, shifting away from compounded weight loss drugs.
Source: Fierce Healthcare